Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice

Section: Article
Published
Sep 1, 2019
Pages
211-229

Abstract

The present study investigated the effect of probiotic bacteria lactobacillus GG (13105 CFU/0.1ml) on the immune response of Swiss BALB/c mice (injected intraperitoneally), against experimental Infection with protoscoleces of Echinococcus granulosus (Postinfection), in comparison with the control group (mice injected with protoscoleces only) for 2-5 months. Another experimental group of mice inoculated (orally) with L.rhamnosus GG (8107 CFU/0.1ml) preinfection with protoscoleces for 3 months. Depending on many criteria including numbers, weights, diameters of developed hydtid cysts, and the percentage of their reduction, the results revealed a significant decrease (P 0.05) (P 0.01) in numbers, weights and diameters of hydatid cysts in treated mice, expressed by the percentage reduction elevation of their numbers to (98%) in mice treated intraperitoneally (2-5 months) post infection, and 95% in mice treated orally 3 months pre infection, as compared with the control groups.

Download this PDF file

Statistics

How to Cite

[1]
A. Ali, اسماء, T. Younis Torki, تسنیم, N. Ali Ahmad, and نعیم, “Use of Lactobacillus rhamnosus GG Agaist Infection with Secondary Hydatid Disease in Swiss BABA/c Mice”, EDUSJ, vol. 28, no. 3, pp. 211–229, Sep. 2019.